Clinical trial
NEXUS Study for the Treatment of de Novo Native Coronary Artery Lesions
NCT00231283 · Cordis US Corp., Industry · Completed
Key facts
| NCT number | NCT00231283 |
|---|---|
| Title | NEXUS Study for the Treatment of de Novo Native Coronary Artery Lesions |
| Official title | A Multicenter, Non-Randomized Study of the CYPHER NxT Sirolimus-Eluting Coronary Stent on BX SONIC OVER-THE-WIRE (OTW) Stent Delivery System(SDS)for the Treatment of de Novo Native Coronary Artery Lesions |
| Lead sponsor | Cordis US Corp., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Coronary Artery Disease |
| Intervention type | Device |
| Interventions | CYPHER NxT SES ON BX SONIC OTW STENT DELIVERY SYSTEM (SDS) |
| Enrollment | 100 |
| Start date | Apr 1, 2004 |
| Completion | Jul 1, 2005 |
| First posted | Oct 4, 2005 |
| Last update posted | Apr 20, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: